Alzheimer's Disease Science is Moving Fast, But the System Needs to Catch Up

Recent breakthroughs in therapies and diagnostics are creating real hope in Alzheimer's disease care — especially for treating early symptomatic stages of the disease. But despite this progress, major healthcare system and awareness gaps still risk leaving too many people behind. We sat down with Laura Steele, Senior Vice President of U.S. Neuroscience at Lilly, to unpack how scientific progress has produced innovations that can improve detection and diagnosis for people with Alzheimer's disease.